TScan Therapeutics(TCRX) - 2024 Q3 - Quarterly Results

Exhibit 99.1 TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update Upcoming oral presentation for the ALLOHA TM Phase 1 heme trial at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition Company to host virtual KOL event featuring Ran Reshef, M.D., M.Sc., on Tuesday, December 10th at 8:00 a.m. ET to discuss clinical updates from the ALLOHA Phase 1 trial and heme development strategy On track to dose first patient with multiplex TCR-T therapy and ...